NCT00470171View on ClinicalTrials.gov

Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis

PHASE2CompletedINTERVENTIONAL
Enrollment

98

Participants

Timeline

Start Date

October 31, 2005

Primary Completion Date

November 30, 2008

Study Completion Date

November 30, 2008

Conditions
Serum Levels of ALAT TransaminasesSerum Markers for Fibrosis and Hepatic Inflammation
Interventions
DRUG

Ursodesoxycholic acid

Trial Locations (1)

75013

La Pitié Salpétrière Hospital, Paris

Sponsors

Lead Sponsor

Axcan Pharma
All Listed Sponsors
lead

Axcan Pharma

INDUSTRY

NCT00470171 - Pilot Study of Ursodesoxycholic Acid in Non-Alcoholic Steatohepatitis | Biotech Hunter | Biotech Hunter